buyModerate
Kevin T Conroy bought $1.0M of EXAS
President and CEO at EXACT SCIENCES CORP. 19,500 shares at an average of $51.35, traded Nov 13, 2024, filed Nov 13, 2024.
Conviction score
50Value
$1.0M
19,500 shares
Holdings after
1,074,191
+2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$1.0M at market
- 0Relative to holdingsHoldings up 1.8%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-126119, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 13, 2024 | POpen-market purchase Common Stock | +19,500 | $51.35 | $1.0M | 1,074,191 | Nov 13, 2024 |
Related signals
Other insiders at EXACT SCIENCES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 6Weak | EXACT SCIENCES CORP | Katherine S Zanotti director | $171k 3,207 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.